Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03936985 · ClinicalTrials.gov registry record
Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 1,464
- Enrollment target
NCT03936985 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 1,464 participants.
The verdict
NCT03936985 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 1,464 participants
- Enrollment target
Study Summary
The goal of the study is to validate a Prescription Drug Monitoring Program-based opioid risk metric to discriminate between low, moderate, and high-risk opioid use disorder. The World Health Organization Alcohol, Smoking, and Substance Involvement Screening Test (WHO ASSIST) will be used as the gold standard instrument that defines patient risk levels. No intervention or hypothesis will be tested.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,464 participants |
| Start Date | 2019-11-04 |
| Est. Completion | 2023-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03936985
The ClinicalTrials.gov registry entry for NCT03936985 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,464 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03936985 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03936985 about?
NCT03936985 is a clinical study titled "Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool". The goal of the study is to validate a Prescription Drug Monitoring Program-based opioid risk metric to discriminate between low, moderate, and high-risk opioid use disorder. The World Health Organization Alcohol, Smoking, and Substance Involvement Screening Test (WHO ASSIST) will be used as the gol...
What is the current status of trial NCT03936985?
This trial is currently completed. The enrollment target is 1,464 participants. The study started on 2019-11-04. Estimated completion is 2023-05-31.
Who is sponsoring clinical trial NCT03936985?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.